Foresite Capital Management V’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.24M Hold
345,191
5.25% 5
2025
Q1
$3.8M Buy
+345,191
New +$3.8M 4.34% 6